Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-363 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-36 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-36 |
filingDate |
2002-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d67aa22015411da2d781986982963ae2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2517d47fbda01830088e1c9659c4a3e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bcdfd6d380c748a04230969f60bc9bd |
publicationDate |
2002-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2002168722-A1 |
titleOfInvention |
Novel cleaved fragments of fibrinogen |
abstract |
The invention provides novel α E CX cleavage fragments of fibrinogen and methods for detecting and purifying these fragments. The method of the invention also includes a diagnostic method for determining fibrinolytic states or atherogenesis in a mammal. Methods of treating disease characterized by fibrinogen metabolism are also disclosed. In addition, the invention also provides monospecific antibodies which are specifically reactive with α E C domain of fibrinogen. Also provided, are DNA and RNA molecules that encode α E CX cleavage fragments of fibrinogen. In addition, the present invention includes a vector and a host cell capable of expressing α E CX cleavage fragments of fibrinogen. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9777054-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007060522-A1 |
priorityDate |
1998-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |